What is the average price target for LIFEMD INC (LFMD) stock?
14 analysts have analysed LFMD and the average price target is 10.07 USD. This implies a price increase of 101.45% is expected in the next year compared to the current price of 5.
LIFEMD INC (LFMD) Forecast, Price Target & Analyst Ratings
NASDAQ:LFMD • US53216B1044
Current stock price
5 USD
+0.32 (+6.84%)
At close:
4.987 USD
-0.01 (-0.26%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for LIFEMD INC (LFMD).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 6, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.23
- Revenue Estimate
- 49.819M
Price Target Details & History
Consensus Price Target and Range
Mean target
$10.07
Upside
+ 101.45%
From current price of $5.00 to mean target of $10.07, Based on 14 analyst forecasts
Low
$8.08
Median
$10.20
High
$15.75
Price Target Revisions
1 Month
1.28%
3 Months
6.76%
Price Target Summary
14 Wall Street analysts provided a forecast for the next 12 months for LFMD. The average price target is 10.07 USD. This implies a price increase of 101.45% is expected in the next year compared to the current price of 5.
The average price target has been revised upward by 6.76% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
LFMD was analyzed by 14 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about LFMD.
In the previous month the buy percentage consensus was at a similar level.
LFMD was analyzed by 14 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-16 | Mizuho | Upgrade | Neutral -> Outperform |
| 2026-03-12 | Freedom Capital Markets | Maintains | Buy -> Buy |
| 2026-03-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-03-10 | BTIG | Reiterate | Buy -> Buy |
| 2025-11-19 | Mizuho | Maintains | Neutral -> Neutral |
| 2025-11-19 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-11-19 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-11-18 | Lake Street | Maintains | Buy -> Buy |
| 2025-11-18 | BTIG | Maintains | Buy -> Buy |
| 2025-11-18 | B. Riley Securities | Maintains | Buy -> Buy |
| 2025-08-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-06 | Lake Street | Maintains | Buy -> Buy |
| 2025-08-06 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-07-14 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-07-10 | Lake Street | Maintains | Buy -> Buy |
| 2025-04-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-11 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-01-08 | Keybanc | Maintains | Overweight -> Overweight |
| 2024-12-10 | Lake Street | Initiate | Buy |
| 2024-12-04 | Mizuho | Initiate | Neutral |
| 2024-11-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-20 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-08-20 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-08-09 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 6, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.23
- Revenue Estimate
- 49.819M
- Revenue Q2Q
- -24.17%
- EPS Q2Q
- -2,395.00%
- Number of Analysts
- 10
Next Earnings Revisions
Revenue (1 Month)
0.57%
Revenue (3 Months)
-2.45%
EPS (1 Month)
-18.42%
EPS (3 Months)
-368.75%
Next Earnings Summary
LFMD is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is -0.23 USD and the consensus revenue estimate is 49.82M USD.
The next earnings revenue estimate has been revised downward by 2.45% in the past 3 months.
Full Analyst Estimates 2026 - 2028
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 152.547M 28.19% | 154.824M 1.49% | 194.055M 25.34% | 228.06M 17.52% | 270.77M 18.73% | 302.36M 11.67% | |
| EBITDA YoY % growth | -7.889M 74.41% | -10.911M -38.30% | -361.2K 96.69% | 8.751M 2,522.76% | 32.349M 269.66% | 46.342M 43.26% | |
| EBIT YoY % growth | -14.489M 58.12% | -20.402M -40.81% | -7.67M 62.41% | -10.344M -34.87% | 7.826M 175.66% | 16.728M 113.75% | |
| Operating Margin | -9.50% | -13.18% | -3.95% | -4.54% | 2.89% | 5.53% | |
| EPS YoY % growth | -0.70 55.41% | -0.54 22.86% | -0.16 70.37% | -0.26 -62.56% | 0.15 158.82% | 0.16 6.67% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.23 -2,395.00% | -0.10 -70.00% | -0.03 56.29% | 0.07 278.50% | 0.06 126.67% | 0.06 160.00% | 0.09 383.33% | 0.09 21.43% |
| Revenue Q2Q % growth | 49.819M -24.17% | 55.069M -11.49% | 59.172M -1.66% | 64.012M 36.58% | 61.841M 24.13% | 66.028M 19.90% | 69.11M 16.80% | 73.019M 14.07% |
| EBITDA Q2Q % growth | -4.758M -191.50% | 2.921M -36.13% | 6.036M -7.18% | 9.557M 780.67% | 5.971M 225.49% | 6.75M 131.09% | 8.478M 40.46% | 9.36M -2.06% |
| EBIT Q2Q % growth | -8.991M -453.59% | -3.588M -295.62% | -631.38K 67.94% | 4.573M 173.48% | 1.089M 112.11% | 1.622M 145.21% | 3.572M 665.74% | 3.742M -18.17% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
44.54%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
8.82%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
163.75%
EBIT Next 5 Year
N/A
LIFEMD INC / LFMD Forecast FAQ
Can you provide the upcoming earnings date for LIFEMD INC?
LIFEMD INC (LFMD) will report earnings on 2026-05-06, after the market close.
What are the consensus estimates for LIFEMD INC (LFMD) next earnings?
The consensus EPS estimate for the next earnings of LIFEMD INC (LFMD) is -0.23 USD and the consensus revenue estimate is 49.82M USD.
What is the consensus rating for LFMD stock?
The consensus rating for LIFEMD INC (LFMD) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.